GlassScriptPhysician profile
Paul Scott Heltzer
NPI 1104809235
$2,123.82
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $340 · 2021: $360 · 2022: $477 · 2023: $496 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $462.99 | 2019-2024 | Slynd |
| Abbvie INC. | $231.61 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $179.96 | 2022-2023 | |
| Therapeuticsmd, INC. | $179.91 | 2019-2022 | |
| Organon LLC | $158.56 | 2021-2024 | Nexplanon, Nuvaring |
| Lupin INC. | $156.61 | 2019-2021 | |
| Evofem Biosciences, INC. | $137.71 | 2021-2023 | Phexxi |
| Scynexis, INC. | $118.76 | 2022 | |
| Agile Therapeutics, INC. | $72.46 | 2021-2023 | Twirla |
| Merck Sharp & Dohme LLC | $63.69 | 2019-2021 | |
| Avion Pharmaceuticals | $61.26 | 2020-2022 | |
| Pfizer INC. | $51.06 | 2021-2022 | |
| Shield Therapeutics INC | $50.69 | 2022-2023 | Accrufer |
| Mylan Pharmaceuticals INC. | $48.43 | 2019-2021 | |
| Astellas Pharma US INC | $45.69 | 2023 | Myrbetriq, Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $32.84 | 2022 | |
| Duchesnay USA Incorporated | $21.76 | 2019 | |
| Ethicon US, LLC | $20.06 | 2019 | |
| Coopersurgical, INC. | $16.42 | 2023 | Paragard T 380a |
| Meditrina | $13.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Heltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.